Gjurasin M, Miklic P, Zupancic B, et al
The mechanisms gut dysbiosis, immune dysregulation, endothelial damage, mitochondrial dysfunction are well-characterised
Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets three receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon
BPC-157, a peptide compound gaining significant attention in the health and wellness community, is heralded for its remarkable therapeutic potential
I always tell my patients that the main side effect of increased energy is increased energy
Local Expertise Proudly serving Melbourne, Palm Bay, Viera, Cocoa Beach, Titusville, and the surrounding Brevard County communities, we understand local needs, climate effects, and lifestyle factors to deliver treatments that truly work